Patient Power Medical Information And Resources Podcasts on Kentucky Blog

Search Podcasts:

Merkel Cell Carcinoma: Who is at risk?

Patient Power - Medical Information and Resources

Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk.

Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk. read less

Download this podcast

Latest Episodes for this Channel

Merkel Cell Carcinoma: Who is at risk?

Wed December 24 2008

Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk.

Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk. read less

High Risk Pregnancy: Concerns for pre-term birth

Wed December 17 2008

A normal pregnancy term lasts about 40 weeks, but babies born prior to 37 weeks are considered pre-term or premature babies. In this special webcast, ... read more

A normal pregnancy term lasts about 40 weeks, but babies born prior to 37 weeks are considered pre-term or premature babies. In this special webcast, Oregon Health and Science University neonatologist Dr. Cynthia McEvoy will help listeners understand the various impacts of high-risk pregnancies. Hear more about warning signs of pre-term labor and health complications surrounding pre-term births. W... read more

Updates on Lymphoma

Tue December 16 2008

Lymphoma is a general term for cancers that develop in the lymphatic system and can be classified as either Hodgkin's disease or non-Hodgkin's lymphom... read more

Lymphoma is a general term for cancers that develop in the lymphatic system and can be classified as either Hodgkin's disease or non-Hodgkin's lymphoma (NHL). Hear an update of the latest lymphoma treatment research following the American Society of Hematology meeting.

New Treatments for the Enlarged Prostate

Tue December 16 2008

The likelihood of an enlarged prostate increases as men age. Enlargement or benign prostatic hyperplasia (BPH) contributes to many problems, including... read more

The likelihood of an enlarged prostate increases as men age. Enlargement or benign prostatic hyperplasia (BPH) contributes to many problems, including urinary complaints, changes in a man's quality of life, interference with daily activities, alterations in sleep and changes in sexual function. In this ihealth program on Patient Power, Dr. Kevin McVary discusses the latest treatments options for an enlarged prostate. Dr. McVary is a urologist on the medical staff of Northwestern Memorial Hospital and professor of Urology at Northwestern University's Feinberg School of Medicine. Dr. McVary begins with an explanation of the prostate gland and what its function is. He goes on to discuss why men have BPH, and he contends that most men at some point in their life will have some manifestation of these lower urinary tract symptoms (LUTS). Dr. McVary explains the various drug therapies available, detailing each treatment and talking about alternative approaches currently being studied. When the condition is severe, surgical treatments become necessary. Dr. McVary helps us to understand the various approaches and the benefits of this option. He also addresses listener questions concerning enlarged prostate at a young age and the relationship between prostate cancer and BPH. If you're looking for information or advice for an enlarged prostate and how best to control your symptoms, this program will be a useful resource for you. read less

Navigating Dilemmas Posed by Prostate Cancer Treatment Options

Wed December 10 2008

With all the treatment options for prostate cancer out there, it can be difficult for men to make a decision. Joining host Andrew Schorr for a debate ... read more

With all the treatment options for prostate cancer out there, it can be difficult for men to make a decision. Joining host Andrew Schorr for a debate on prostate cancer treatments is Dr. Bruce Dalkin, a urologic oncologist at the Seattle Cancer Care Alliance. Two patients also join the program to share their stories. Ted Girgus suffers from stage IV prostate cancer, and Peter Frishauf received a diagnosis of high PSA levels but had a negative biopsy. Peter is also the founder of Medscape, one of the leading websites to educate doctors. In addition to his work as an oncologist, Dr. Dalkin studies how well different treatments work. He describes how this research is conducted, what he has learned and what it means for patients. Dr. Dalkin discusses what his research has shown about the specific treatment options, including cryotherapy, brachytherapy, immunotherapy and finasteride. He also talks about when treatment is necessary and how it is possible to overtreat patients in certain situations. Ted describes his journey with prostate cancer, from diagnosis to brachytherapy treatment 12 years ago. Peter discusses his experiences with various treatments and explains why he decided to seek out better care than his first doctor could give. Dr. Dalkin's research sparks a debate about the effectiveness of treatments, and how to know whether a certain treatment is effective. Listen to this webcast if you or someone you know is worried about prostate cancer. The guests talk about treatments for patients who have been diagnosed, as well as people like Peter, who have been able to prevent onset. Listen now to learn more. read less